Dicycloverin Hydrochloride en es it fr

Dicycloverin Hydrochloride Brand names, Dicycloverin Hydrochloride Analogs

Dicycloverin Hydrochloride Brand Names Mixture

  • No information avaliable

Dicycloverin Hydrochloride Chemical_Formula

C19H35NO2

Dicycloverin Hydrochloride RX_link

http://www.rxlist.com/cgi/generic/dicyc.htm

Dicycloverin Hydrochloride fda sheet

Dicycloverin_Hydrochloride FDA

Dicycloverin Hydrochloride msds (material safety sheet)

Dicycloverin Hydrochloride Synthesis Reference

No information avaliable

Dicycloverin Hydrochloride Molecular Weight

309.487 g/mol

Dicycloverin Hydrochloride Melting Point

No information avaliable

Dicycloverin Hydrochloride H2O Solubility

No information avaliable

Dicycloverin Hydrochloride State

Solid

Dicycloverin Hydrochloride LogP

5.476

Dicycloverin Hydrochloride Dosage Forms

Capsule

Dicycloverin Hydrochloride Indication

For the treatment of functional bowel/irritable bowel syndrome

Dicycloverin Hydrochloride Pharmacology

Dicyclomine is an anticholinergic drug, a medication that reduces the effect of acetylcholine, a chemical released from nerves that stimulates muscles, by blocking the receptors for acetylcholine on smooth muscle (a type of muscle). It also has a direct relaxing effect on smooth muscle. Dicyclomine is used to treat or prevent spasm in the muscles of the gastrointestinal tract in the irritable bowel syndrome. In addition, Dicyclomine inhibits gastrointestinal propulsive motility and decreases gastric acid secretion and controls excessive pharyngeal, tracheal and bronchial secretions.

Dicycloverin Hydrochloride Absorption

No information avaliable

Dicycloverin Hydrochloride side effects and Toxicity

No information avaliable

Dicycloverin Hydrochloride Patient Information

Dicyclomine may produce drowsiness or blurred vision. The patient should be warned not to engage in activities requiring mental alertness, such as operating a motor vehicle or other machinery or to perform hazardous work while taking this drug.

Dicyclomine is contraindicated in infants less than 6 months of age and in nursing mothers. .

In the presence of a high environmental temperature, heat prostration can occur with drug use (fever and heat stroke due to decreased sweating).

If symptoms occur the drug should be discontinued and a physician contacted.

Dicycloverin Hydrochloride Organisms Affected

Humans and other mammals